Dr. Mark S. Burke, MD

Dr. Burke practices at Erie County Medical Center in Buffalo, New York, part of Erie County Medical Center.

Dr. Burke's NPI, 1730341074, was assigned on June 27, 2008. Dr. Burke graduated from State University of New York at Stony Brook, School of Medicine in 2002. Dr. Burke holds New York license 244867.

Dr. Burke's primary practice is Erie County Medical Center, at 462 Grider Street, Buffalo, NY 14215 in Erie County. The practice phone is (716) 898-3936.

Dr. Burke's primary practice is Erie County Medical Center in Buffalo, New York, part of Erie County Medical Center. The medical group on file is Erie County Medical Center (ECMC). Dmand AI also links Dr. Burke to 1 more dialysis center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Burke practices, 2 sites in all. Vendor and product names are available with a free account.

Plastic and reconstructive surgery is Dr. Burke's primary specialty in the NPI Registry, under taxonomy code 2086S0122X. Dr. Burke is licensed in New York.

CMS data shows 35 Medicare services from Dr. Burke across 2 procedure codes in 2024, all of them office visits, for 47 Medicare patients. Medicare paid $2,109 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 47 Medicare patients who saw Dr. Burke in 2024. The largest group is 65 to 74, with 18 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 34% are also on Medicaid. Their average risk score is 1.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Burke's median patient age at 70, with 42% women.

In 2024, Dr. Burke wrote 20 Medicare Part D claims for 18 patients. 100% of them were for generic drugs. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $97 in total drug cost. In 2023, CMS named 17 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Burke for performance year 2024, reported as part of a group. Dr. Burke accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 18 procedures of melanoma (skin cancer) excision by Dr. Burke, more than 73% of the clinicians it reports for that procedure.

Mastectomy: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 12 papers to Dr. Burke, published from 2019 to 2025. 2019 was the busiest year, with 3. The most frequent topics are Carcinoma, Squamous Cell, Neck Dissection and Postoperative Complications. Dr. Burke has published most often in Ann Plast Surg. Dr. Burke's most frequent co-authors are Thom R. Loree, MD, Saurin R. Popat, MD and Tatiana Viktorovna Boyko, MD.

CMS Open Payments shows 83 general payments to Dr. Burke from 21 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 59% of the total. Integra LifeSciences Corporation paid the most, $35,758.

Dr. Burke graduated from State University of New York at Stony Brook, School of Medicine in 2002.